Literature DB >> 12171577

GABA(A) receptors as molecular sites of ethanol action. Direct or indirect actions?

Luis G Aguayo1, Robert W Peoples, Hermes H Yeh, Gonzalo E Yevenes.   

Abstract

Despite the fact that ethanol is one of the most widely used psychoactive agents, the mechanisms and sites of action by which it modifies brain functions are only now being elucidated. Studies over the last decade have shown that ethanol can specifically alter the function of several ligand-activated ion channels including N-methyl-D-aspartate (NMDA), serotonin (5-HT(3)), glycine and GABA(A) receptors. After several years of extensive research in this field, the resolution of what, where and how ethanol modifies GABA(A) receptors continues to be controversial. For example, after demonstrating that ethanol was able to alter Cl(-) flux in synaptoneurosomes and cultured neurons, several electrophysiological studies were unable to show enhancement of the GABA(A) receptor current in single neurons. The lack of positive results with low ethanol concentrations was interpreted as being due to receptor heterogeneity and differences in intracellular modulation by protein kinases and calcium. The existence of high receptor heterogeneity with respect to ethanol sensitivity has been supported by studies done in a variety of cell types which showed that ethanol potentiated some, but not other neurons. Adding to this complexity, it was shown that while some hippocampal GABA(A) receptors can be affected by ethanol concentrations between 1 and 100 mM, others are only sensitive to concentrations above 200 mM. The curve of the relationship between low ethanol concentrations and current enhancement suggests a high degree of complexity in the molecular interaction because of its steepness and "inverted" U shape. Similarly, the effects of ethanol on GABA(A) receptors seems much more complex than those of benzodiazepines, barbiturates and neurosteroids. The major problem encountered in advancing understanding of the mechanism of ethanol action in native neuronal receptors has been the large variability detected in ethanol sensitivity. For example, several studies have shown that only some groups of neurons are sensitive to pharmacologically relevant concentrations of ethanol (1-100 mM). This receptor sensitivity variability has not been resolved using recombinant expression systems. For example, studies performed in recombinant receptors, although important for elucidating molecular requirements, have shown that they are less sensitive to ethanol suggesting that neuronal substrates are important for ethanol actions. In this review, we discuss the possibility that ethanol's action on the GABA(A) receptor may not be due solely to a direct interaction with the receptor protein, but that its effects could also be modulated by intracellular regulation, and that this latter effect is the more physiologically relevant one. Data in cortical and hippocampal neurons suggest that ethanol action on the receptor is labile, and that it also depends on repetitive stimulation and neuron integrity. In addition, the action of ethanol can be modified by activation of protein kinases and neuronal development. Finally, we discuss that the best approach for studying the interaction between the receptor and ethanol is through the combined use of recombinant receptors and overexpression in neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171577     DOI: 10.2174/1568026023393426

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  50 in total

1.  Molecular requirements for ethanol differential allosteric modulation of glycine receptors based on selective Gbetagamma modulation.

Authors:  Gonzalo E Yevenes; Gustavo Moraga-Cid; Ariel Avila; Leonardo Guzmán; Maximiliano Figueroa; Robert W Peoples; Luis G Aguayo
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

Review 2.  Low dose acute alcohol effects on GABA A receptor subtypes.

Authors:  Martin Wallner; H Jacob Hanchar; Richard W Olsen
Journal:  Pharmacol Ther       Date:  2006-07-11       Impact factor: 12.310

3.  Alcohol-sensitive GABA receptors and alcohol antagonists.

Authors:  Steven M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

Review 4.  Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Authors:  Philippe De Witte; John Littleton; Philippe Parot; George Koob
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Effect of chronic administration of ethanol on the regulation of the delta-subunit of GABA(A) receptors in the rat brain.

Authors:  C R Marutha Ravindran; Ashok K Mehta; Maharaj K Ticku
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

6.  Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to alpha4/6beta3delta GABAA receptors.

Authors:  H Jacob Hanchar; Panida Chutsrinopkun; Pratap Meera; Porntip Supavilai; Werner Sieghart; Martin Wallner; Richard W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

7.  Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal.

Authors:  Enrico Sanna; Maria Cristina Mostallino; Fabio Busonero; Giuseppe Talani; Stefania Tranquilli; Manuel Mameli; Saturnino Spiga; Paolo Follesa; Giovanni Biggio
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

Review 8.  GABAA receptor polymorphisms in alcohol use disorder in the GWAS era.

Authors:  Mairi Koulentaki; Elias Kouroumalis
Journal:  Psychopharmacology (Berl)       Date:  2018-05-02       Impact factor: 4.530

Review 9.  Alcohol disrupts sleep homeostasis.

Authors:  Mahesh M Thakkar; Rishi Sharma; Pradeep Sahota
Journal:  Alcohol       Date:  2014-11-11       Impact factor: 2.405

Review 10.  [The importance of sleep for healthy alcohol consumers and alcohol dependent patients].

Authors:  H Gann; D van Calker; B Feige; D Riemann
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.